Photo credit: Njiiri Karago/MSF Press release Press release | 17 August 2023 HIV/AIDS MSF refuses to sign ViiV’s last-minute NDA for access to most-effective HIV prevention drug CAB-LA 4 min
Photo credit: MSF/Michel Lunanga Press release Press release | 18 July 2023 Vaccines Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery 4 min
Photo credit: Oksana Parafeniuk Press release Press release | 17 July 2023 Tuberculosis MSF calls for commitment from pharma corporation J&J to not enforce extended patents on lifesaving TB drug as main patent expires in India, opening door to affordable generics 5 min
Photo credit: Prem Hessenkamp Press release Press release | 13 July 2023 Intellectual property and trade Tuberculosis TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries 2 min
Photo credit: Marta Soszynska/MSF Press release Press release | 13 July 2023 HIV/AIDS Intellectual property and trade Colombia Colombia to challenge AIDS drug patents 3 min
Photo credit: Nicolas Guyonnet/MSF Press release Press release | 12 July 2023 COVID-19 MSF welcomes pro-access recommendations in European Parliament COVID report 3 min
Photo credit: MSF/Johnny Vianney Bissakonou Press release Press release | 12 June 2023 Vaccines MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old 3 min
Photo credit: Florence Miettaux Press release Press release | 26 May 2023 Diagnostics MSF welcomes important resolution at World Health Assembly to strengthen countries’ disease testing capacity 3 min
